Sign in

CIK 0001774857 · <br>Emerging growth company

Aardvark Therapeutics, Inc.

Sign in to watch
Ticker
AARD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
821606367
Phone
(858) 225-7696
Business address
4370 LA JOLLA VILLAGE DRIVE, SUITE 1050, SAN DIEGO, CA, 92122
  1. 4 Conversion Director acquired 133,364 shares (conversion)
  2. 4 Conversion 10% owner acquired 2,050,902 shares (conversion)
  3. 4 Open-market buy Chief Executive Officer bought 16,542 shares at $16.00 ($264,672)
  4. 4 Open-market buy Chief Financial Officer bought 10,000 shares at $16.00 ($160,000)
  5. 4 Open-market buy Former 10% Owner bought 187,500 shares at $16.00 ($3,000,000)
  6. 8-K Event Bylaws or fiscal year change · Other events
  7. S-8 Other Securities Offered to Employees in Benefit Plans
  8. 424B4 Offering Prospectus
  9. EFFECT Other Notice of Effectiveness
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 5 of 6 · 117 filings